抗生素在肝、肺癌血管内介入治疗中的应用  

Antibioltic used in intrvascular interventional therapy of hepatocarcinoma and pulmonary carcinoma

作　　者：吴熙中[1] 陈艳萍[2] 

机构地区：[1]汕头大学医学院第二附属医院介入室,广东汕头515041 [2]汕头大学医学院第一附属医院,广东汕头515041

出　　处：《中国介入影像与治疗学》2005年第2期130-132,共3页Chinese Journal of Interventional Imaging and Therapy

摘　　要：　目的　分析肝癌、肺癌介入治疗围术期应用抗生素合理性和重要性。方法　分析 356 例肝癌、肺癌介入治疗围术期抗生素应用情况。结果　356例肝癌、肺癌介入治疗过程中通过合理应用抗生素,感染控制有效率达 100%;介入治疗后出院两周,出现高热及白细胞低下的3例危重患者,经抗生素治疗后1例获救,2例死亡。结论　在肝癌、肺癌介入治疗过程中,合理应用抗茵素是必要的。对于介入治疗后高热及白细胞计数低下患者,要及时给予治疗。Objective To analyze the significance of antibioltic used in interventional therapy of hepatocarcinoma and pulmonary carcinoma. Methods The situation of 356 cases used antibioltc for interventional therapy of hepatocarcinoma and pulmonary carcinoma were analyzed. Results The response rate of infection control was 100% when 356 cases with hepatocarcinoma and pulmonary carcinoma used antibioltic reasonably during interventional therapy. Two weeks after interventional therapy, 3 severity cases with hyperpyrexia and leucocytopenia, one was saved and the opther two dead after treatment. Conclusion It is necessary to use antibioltic reasonably during the interventional therapy of hepatocarcinoma and pulmonary carcinoma.

关 键 词：血管内介入治疗 肺癌介入治疗 合理应用抗生素 介入治疗后 治疗过程 白细胞低下 白细胞计数 应用情况 感染控制 危重患者 围术期 肝癌 合理性 有效率 抗菌素 高热 

分 类 号：R735.7[医药卫生—肿瘤] R734.2[医药卫生—临床医学]